Neonatal Intensive Care
Neonatal Intensive Care Channel @newborn Administrator: @Vafaeeali Technical Supervisor of the Channel: Ali Vafaee, M.Sc. in Neonatal Intensive Care Ph.D. Candidate in Nursing Ms. Aida Safaei Fakhr M.Sc. in Neonatal Intensive Care
نمایش بیشتر📈 تحلیل کانال تلگرام Neonatal Intensive Care
کانال Neonatal Intensive Care (@newborn) در بخش زبانی انگلیسی بازیگری فعال است. در حال حاضر جامعه شامل 17 902 مشترک است و جایگاه 1 360 را در دسته پزشکی و رتبه 19 277 را در منطقه إيران دارد.
📊 شاخصهای مخاطب و پویایی
از زمان ایجاد در невідомо، پروژه رشد سریعی داشته و 17 902 مشترک جذب کرده است.
بر اساس آخرین دادهها در تاریخ 22 اکتبر, 2026، کانال فعالیت پایداری دارد. در ۳۰ روز گذشته تغییر اعضا برابر 127 و در ۲۴ ساعت گذشته برابر 8 بوده و همچنان دسترسی گستردهای حفظ شده است.
- وضعیت تأیید: تأیید نشده
- نرخ تعامل (ER): میانگین تعامل مخاطب 18.63% است و در ۲۴ ساعت نخست پس از انتشار، محتوا معمولاً 5.54% واکنش نسبت به کل مشترکان کسب میکند.
- دسترسی پستها: هر پست به طور میانگین 3 334 بازدید دریافت میکند. در اولین روز معمولاً 991 بازدید جمعآوری میشود.
- واکنشها و تعامل: مخاطبان بهطور فعال حمایت میکنند؛ میانگین واکنش به هر پست 14 است.
- علایق موضوعی: محتوا بر موضوعات کلیدی مانند است, مراقبت, نوزادان, برای, نوزاد تمرکز دارد.
📝 توضیح و سیاست محتوایی
نویسنده این فضا را محل بیان دیدگاههای شخصی توصیف میکند:
“Neonatal Intensive Care Channel
@newborn
Administrator: @Vafaeeali
Technical Supervisor of the Channel:
Ali Vafaee, M.Sc. in Neonatal Intensive Care
Ph.D. Candidate in Nursing
Ms. Aida Safaei Fakhr M.Sc. in Neonatal Intensive Care”
به لطف بهروزرسانیهای پرتکرار (آخرین داده در تاریخ 23 اکتبر, 2026)، کانال همواره بهروز و دارای دسترسی بالاست. تحلیلها نشان میدهد مخاطبان بهطور فعال با محتوا تعامل دارند و آن را به نقطه اثرگذاری مهم در دسته پزشکی تبدیل کردهاند.
در حال بارگذاری دادهها
| تاریخ | رشد مشترکین | اشارات | کانالها | |
| 23 اکتبر | +5 | |||
| 22 اکتبر | +9 | |||
| 21 اکتبر | +9 | |||
| 20 اکتبر | +8 | |||
| 19 اکتبر | 0 | |||
| 18 اکتبر | +13 | |||
| 17 اکتبر | +1 | |||
| 16 اکتبر | +5 | |||
| 15 اکتبر | +3 | |||
| 14 اکتبر | +3 | |||
| 13 اکتبر | +3 | |||
| 12 اکتبر | 0 | |||
| 11 اکتبر | +3 | |||
| 10 اکتبر | +10 | |||
| 09 اکتبر | +5 | |||
| 08 اکتبر | +5 | |||
| 07 اکتبر | +3 | |||
| 06 اکتبر | +12 | |||
| 05 اکتبر | +1 | |||
| 04 اکتبر | +7 | |||
| 03 اکتبر | +3 | |||
| 02 اکتبر | +16 | |||
| 01 اکتبر | +2 |
| 2 | Park's Pediatric Cardiology for Practitioners, Eighth Edition 2027 #Exclusive_Books
Thanks to My lovely Wife for great effort ❤️ | 1 207 |
| 3 | بدون متن... | 1 415 |
| 4 | IAP_Textbook_of_Pediatric_and_Neonatal_Emergencies_afkebooks_com.pdf | 1 378 |
| 5 | بدون متن... | 1 734 |
| 6 | Red_Book_Atlas_of_Pediatric_Infectious_Diseases_American_Academy.pdf | 1 592 |
| 7 | بدون متن... | 1 978 |
| 8 | An overview of the pathophysiological features of HIE showing stages and etiologies of brain injury.
@newborn
@newborn | 3 517 |
| 9 | +1 Grand Rounds October 2026 | 2 700 |
| 10 | 🫁 Can a ventilator adjust oxygen by itself?
One of the major challenges in caring for extremely preterm infants is maintaining SpO₂ within the target range.
Both hypoxemia and hyperoxemia can be harmful. Therefore, NICU clinicians continuously adjust the FiO₂ according to changes in the infant’s oxygen saturation.
But what if the machine could do this automatically?
🔬 What does the latest evidence show?
A large multicenter randomized controlled trial published in The Lancet Child & Adolescent Health evaluated automatic versus manual oxygen control in extremely preterm infants.
The study included more than 1,000 infants born at 23–27+6 weeks of gestation across 32 NICUs.
In the intervention group, a closed-loop automated FiO₂ control system continuously used SpO₂ data to adjust the oxygen concentration.
Interestingly, the primary clinical outcome was not significantly different:
🔹 Death, NEC, BPD, or severe ROP:
39% with automated oxygen control
vs.
41% with manual control
There was also no significant difference in the individual outcomes of:
• Mortality
• Necrotizing enterocolitis (NEC)
• Bronchopulmonary dysplasia (BPD)
• Severe retinopathy of prematurity (ROP)
📌 So, does automated oxygen control not work?
Not necessarily.
Previous studies have shown that closed-loop systems can increase the amount of time infants spend within the target SpO₂ range and may reduce episodes of both hypoxemia and hyperoxemia.
They may also reduce the workload associated with frequent manual FiO₂ adjustments.
However, the 2026 trial suggests that better oxygen targeting does not automatically translate into better major clinical outcomes.
⚠️ Clinical message
Automated FiO₂ control should not be considered a replacement for clinical judgment.
The technology may become an important tool for reducing oxygen fluctuations and supporting bedside clinicians, but careful monitoring and appropriate clinical decision-making remain essential.
🔑 The future of neonatal oxygen therapy may not be
Human vs. machine
but rather:
Human + intelligent technology.
The goal is not simply to achieve a target SpO₂ value, but to minimize the dangerous swings between hypoxemia and hyperoxemia.
📚 Reference
Franz AR, Maiwald CA, Niemarkt HJ, et al. Automatic versus manual control of oxygen and neonatal clinical outcomes in extremely preterm infants: a multicentre, parallel-group, randomised, controlled, superiority trial. Lancet Child Adolesc Health. 2026;10(3):179–188. doi:10.1016/S2352-4642(25)00351-7.
@newborn
@newborn | 3 187 |
| 11 | بدون متن... | 4 115 |
| 12 | Therapeutic Hypothermia in Neonatal HIE: Clinical Criteria, 72-Hour Protocol, and Systems Management
Therapeutic hypothermia in neonatal HIE: Clinical criteria, 72-hour protocol, and systems management
- Inclusion: GA ≥36w, age ≤6h, pH≤7.0/BE≥-16, moderate-severe Sarnat
- Cool to 33.5±0.5°C for 72h; monitor q15min first 4h then q1h; rewarm ≤0.5°C per 1-2h
- Dexmedetomidine for shivering, low-dose opioids; MAP 40-50 mmHg; glucose 2.6-8.0 mmol/L
- Abort: refractory hypotension on inotropes, persistent hypoxemia despite 100% O2/iNO, severe coagulopathy
Read the full guide on NeoFast | 2 433 |
| 13 | بدون متن... | 2 760 |
| 14 | Neonatal_Disease_From_Pathophysiology_to_Current_and_Emerging_Therapeutic.pdf | 2 649 |
| 15 | بدون متن... | 2 545 |
| 16 | Optimizing Neurodevelopment in Severe Bronchopulmonary Dysplasia: BSRI and OSST Scores in NICU Chronic Care
Chronic care scoring for severe BPD: BSRI and OSST scales replace aggressive weaning with structured, brain-protective monitoring.
- BSRI: 5-item bedside tolerance score (Interaction, Midline, Extension, Tachypnea, Respiratory Effort); score ≥8 = proceed, lower = stop handling.
- Tachypnea cutoffs: RR >80/min or tachypnea-apnea = instability; RR <60/min = stable.
- OSST: weekly 4-domain score (Respiratory, Neuroregulation, Infection/Inflammation, Nutrition/Growth).
- CCBPD model cut Bayley <70 rates: cognitive/language 49.8% to 15.2%, motor delay 41.7% to 10.9%, no rise in accidental extubation.
Read the full guide on NeoFast | 2 730 |
| 17 | Neonatal Vascular Access: UVC & IO – Indications, Timing, and Team Coordination in Advanced Resuscitation
UVC and intraosseous access for emergency neonatal resuscitation
- HR < 60 bpm after 60 seconds compressions with 100% oxygen; establish UVC or IO access
- UVC preferred; IO alternative when UVC not feasible; epinephrine every 3-5 minutes
- IO insertion 2 cm below and 1-2 cm medial to tibial tuberosity; flush with 3-5 mL NS
- Compressor moves to head of bed to free space for UVC insertion
Read the full guide on NeoFast | 2 665 |
| 18 | The Neonatal Resuscitation Blueprint: A Visual Guide to the First 60 Seconds (NRP 9th Edition)
NRP 9th algorithm for first 60 seconds: warm, assess, escalate by HR thresholds.
- Target HR >100 bpm; <60 bpm requires 3:1 compressions + 100% oxygen
- Epinephrine 0.1 mg/mL via UVC/IO every 3-5 min if HR <60 bpm
- Ventilation 40-60 breaths/min; PIP 20-30 cm H2O, PEEP 5 cm H2O
- SpO2 targets: 60-70% at 2 min, 70-75% at 3 min, 75-80% at 4 min, 80-85% at 5 min, 85-95% at 10 min
- Initial FiO2: 21% (≥35 wks), 21-30% (32-34 wks), ≥30% (<32 wks)
Read the full guide on NeoFast | 2 758 |
| 19 | Critical Management of Neonatal Hyperbilirubinemia: From AAP 2022 Guideline to Bedside Decision with Neofast
Neonatal hyperbilirubinemia: AAP 2022 thresholds and risk factors
- Phototherapy 8.9 mg/dL, escalation 14.1 mg/dL, exchange transfusion 20.0 mg/dL
- Risk factors lower thresholds: gestational age <38w, albumin <3.0 g/dL, hemolytic disease, G6PD, sepsis
- IVIG 400-1000 mg/kg/dose for positive Coombs; intensive phototherapy ≥30 μW/cm²/nm reduces bilirubin 30-40% in 24h
- Exchange transfusion: 170 mL/kg, removes 85% RBCs, monitor bilirubin every 2 hours
Read the full guide on NeoFast | 3 191 |
| 20 | Severe MAS & APHN: The Advanced Management Protocol
Advanced management of severe meconium aspiration and neonatal pulmonary hypertension
- SpO2 91-95% pre-ductal, PaCO2 6-8 kPa; >10% pre/post-ductal gradient confirms shunting
- Milieu: ionized calcium >1.0, magnesium ≥1.0 mmol/L, hemoglobin ≥120 g/L
- OI >20: iNO 20 ppm + HFOV; OI >40: ECLS/ECMO referral
- Inotropes: Milrinone 0.25 mcg/kg/min or Dobutamine 5-10 + Adrenaline 0.05-0.2 mcg/kg/min; Hydrocortisone 2.5 mg/kg 6-hourly if refractory
Read the full guide on NeoFast | 3 390 |
